Ex Parte SCHULTZ et al - Page 4



          Appeal No. 2003-0739                                                        
          Application No. 09/319,763                                                  

          modify the prior art or to combine prior art references to arrive           
          at the claimed invention.  Such reason must stem from some                  
          teaching, suggestion or implication in the prior art as a whole             
          or knowledge generally available to one having ordinary skill in            
          the art.  Uniroyal Inc. v. Rudkin-Wiley Corp., 837 F.2d 1044,               
          1051, 5 USPQ2d 1434, 1438 (Fed. Cir.), cert. denied, 488 U.S. 825           
          (1988); Ashland Oil, Inc. v. Delta Resins & Refractories, Inc.,             
          776 F.2d 281, 293, 227 USPQ 657, 664 (Fed. Cir. 1985), cert.                
          denied, 475 U.S. 1017 (1986); ACS Hospital Systems, Inc. v.                 
          Montefiore Hospital, 732 F.2d 1572, 1577, 221 USPQ 929, 933 (Fed.           
          Cir. 1984).  These showings by the Examiner are an essential part           
          of complying with the burden of presenting a prima facie case of            
          obviousness.  Note In re Oetiker, 977 F.2d 1443, 1445, 24 USPQ2d            
          1443, 1444 (Fed. Cir. 1992).                                                
               With respect to the Examiner’s 35 U.S.C. § 103(a) rejection            
          of appealed independent claims 1 and 6, Appellants assert that              
          the Examiner has failed to establish a prima facie case of                  
          obviousness since all of the claimed limitations are not taught             
          or suggested by the applied Canfield reference.  In particular,             
          Appellants contend (Brief, pages 3 and 4) that the Examiner has             
          misinterpreted the disclosure of Canfield as providing a                    
          description of the claimed selective inhibition of a                        
                                         -4-                                          




Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007